Tirzepatide reduces body weight and slows progression to diabetes in patients with obesity and prediabetes
Three-year study shows significant and sustained weight reduction with tirzepatide and a markedly lower risk of progression from prediabetes to type 2 diabetes.
Register for free access or login.
Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.
Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.